-The Business Standard The proposed pharma pricing policy may give room to drug makers to escape price control. While the policy is primarily aimed at making essential Medicines affordable, many feel the spirit is missing in the recommendations put forward by a group of ministers a few days ago. For instance, the ministerial panel has proposed to regulate prices of only 348 essential Medicines and keep combination products out of control —...

-The Times of India India will, for the first time, put a cap on the maximum price at which essential drugs, like some commonly used anti-AIDS and anti-cancer drugs, besides a horde of painkillers, anti-TB drugs, sedatives, lipid lowering agents and steroids, can be sold in the country. In a landmark decision, a group of ministers (GoM) headed by agriculture minister Sharad Pawar on Thursday cleared the proposal to bring all 348...

-The Telegraph A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for Medicines. The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments — from painkillers and antibiotics to asthma medications and drugs against high blood...

-The Times of India With finance minister P Chidambaram recently declaring at a full Planning Commission meeting that cash transfers may replace subsidies for food, fertilizers and fuel by the end of the 12th five-year Plan, the controversial proposal has again taken centre stage. A recently concluded pilot project which substituted ration cards with Rs 1,000 transferred monthly to families throws light on the pros and cons of the scheme. The study...

-The Times of India MUMBAI: Consumers can look forward to a reduction in prices of essential Medicines, with the Sharad Pawar-led Group of Ministers (GoM) planning to take a final decision on the pharmaceutical policy soon. The GoM will meet on September 27 to examine options under the market price-based mechanism to cap prices of drugs, which may lead to a reduction ranging from 25% to even 90% in some cases,...